Pharmacology of traumatic brain injury: where is the "golden bullet"?
about
The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injuryCathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug CandidateRelevance of gap junctions and large pore channels in traumatic brain injuryPredicting outcome after childhood brain injuryMolecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"?Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategiesAnimal models of traumatic brain injuryTraumatic brain injury and NADPH oxidase: a deep relationshipCB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in MiceCombination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.Caffeic Acid phenethyl ester protects blood-brain barrier integrity and reduces contusion volume in rodent models of traumatic brain injury.D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.A modified controlled cortical impact technique to model mild traumatic brain injury mechanics in mice.Traumatic brain injury: an overview of pathobiology with emphasis on military populations.The relationship between transient zinc ion fluctuations and redox signaling in the pathways of secondary cellular injury: relevance to traumatic brain injury.Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury.Vascular endothelial growth factor increases neurogenesis after traumatic brain injury.Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammationCritical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury.Give progesterone a chance.Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injuryA double-blind, placebo-controlled intervention trial of 3 and 10 mg sublingual melatonin for post-concussion syndrome in youths (PLAYGAME): study protocol for a randomized controlled trialOuabain improves functional recovery following traumatic brain injuryCortical endogenic neural regeneration of adult rat after traumatic brain injuryCCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injuryEndocannabinoids and traumatic brain injuryChallenging the role of adaptive immunity in neurotrauma: Rag1(-/-) mice lacking mature B and T cells do not show neuroprotection after closed head injury.Medical therapies for concussion.Traumatic brain injury - modeling neuropsychiatric symptoms in rodents.Potassium Aspartate Attenuates Brain Injury Induced by Controlled Cortical Impact in Rats Through Increasing Adenosine Triphosphate (ATP) Levels, Na+/K+-ATPase Activity and Reducing Brain Edema.Phenoxybenzamine is neuroprotective in a rat model of severe traumatic brain injury.Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury.Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.Neuroinflammation: beneficial and detrimental effects after traumatic brain injury.Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III.Pediatric Traumatic Brain Injury and Autism: Elucidating Shared Mechanisms.High Ca2+ Influx During Traumatic Brain Injury Leads to Caspase-1-Dependent Neuroinflammation and Cell Death.Temporal profile of cerebrospinal fluid, plasma, and brain interleukin-6 after normothermic fluid-percussion brain injury: effect of secondary hypoxia.Validation of Acoustic Wave Induced Traumatic Brain Injury in Rats.
P2860
Q24601910-6BD76B26-4AEA-496F-9521-B17D86B07385Q26782938-9CB509DB-7E89-4D50-B473-1E599D6DDF21Q26820817-7B60C8EA-C8B9-4884-A922-409A5BFF2122Q26825547-A5BAAD8C-70B1-442D-A266-A1A4683A3404Q26825724-A7963F33-5E9C-4D79-9D83-1CD904494C38Q27024426-2326A8E3-7A36-414D-BD56-849C54C1AD0EQ27025091-3A13748C-B482-4CF6-988D-BFB4F3943B37Q28080903-19F8F3C0-445F-41D1-BC00-CFEE0AC5ED3BQ28315817-DA9BFCE1-6F92-4EA8-96D6-FCDF9FE6D27AQ28397361-6EF08BAA-63E8-4548-A016-B6A25FD91B44Q30360306-3E42B569-DE3C-4BDB-9521-9F34AD3AC0A8Q30513157-A1663EFE-1C04-48E1-B2D8-BE4B50B16732Q33615809-6FB5AC8D-15FE-49D7-999F-D936E9268058Q33771195-BA936E30-F94B-43E9-8C22-45B2ED6A87FBQ33791943-5D83D010-0F98-44FA-99EC-A50B98DFA776Q33854617-F5635B89-B090-4996-B867-81733E771B92Q34043822-3D22AD15-918F-48E7-B18B-4F818B7DF93DQ34171058-0B8FD352-2A1B-4F0A-9FBB-471EC42C60B7Q34171305-075D8F79-5AEC-415E-8BA3-25B4256F4362Q34224919-F536BC1E-141B-45FA-AFD8-E57C56FFD934Q34319455-0B780D61-E44F-4862-90D6-D18B9585309BQ34441698-FF1D41D3-4EB4-4FA7-9F45-06D2D6425925Q34486287-EA250A6B-E6BA-40FE-9764-7F8B10C369E8Q34546792-D7BBD7E0-6DB0-495C-A34C-94CA7271B0E3Q34906785-2FE4A6AC-FB66-4644-BB9C-10CD71FB6B1DQ34946373-418C0900-C705-4287-B77C-0DADA15A6FE5Q35193282-293570D0-4DC7-46A4-BB4C-2DE81E7A3246Q35886721-AFA554AD-7E2D-43E0-A1B3-11EF5A99E7EBQ35986783-D6AC1556-4CD8-4DB5-AC0C-6569A6071C67Q37218200-B5FF8F9B-0E3E-4879-B7DE-6DFAE2ABCE84Q37523891-A2ADAC6B-278E-4AE8-856C-07ABE23CDB86Q37535647-D345C707-A800-4240-9809-C2F41EAB4C0FQ37667680-B59395E1-AEBE-4E9E-AD08-DD867D45BF3CQ37832963-0DDB0682-E283-459C-9C72-95C9FB8B57D1Q38072367-8B3443B8-B7FB-40B4-87F2-7950596A8563Q38794262-AC1F9549-BF72-4D2E-85FB-AB8FAC0F90FCQ39028166-9D5A8354-A5C0-48DA-AC65-2A15F3C0F094Q39690956-5CD67900-ADA7-4770-BC1D-E574E83E13AAQ39714539-564DC4F1-09E9-4AB5-8E27-45BD832F9C55Q41049214-81587588-D16A-4846-BA70-18DCA1D597B5
P2860
Pharmacology of traumatic brain injury: where is the "golden bullet"?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacology of traumatic brain injury: where is the "golden bullet"?
@en
Pharmacology of traumatic brain injury: where is the "golden bullet"?
@nl
type
label
Pharmacology of traumatic brain injury: where is the "golden bullet"?
@en
Pharmacology of traumatic brain injury: where is the "golden bullet"?
@nl
prefLabel
Pharmacology of traumatic brain injury: where is the "golden bullet"?
@en
Pharmacology of traumatic brain injury: where is the "golden bullet"?
@nl
P2093
P2860
P1433
P1476
Pharmacology of traumatic brain injury: where is the "golden bullet"?
@en
P2093
Esther Shohami
Haitham Mutlak
Kathryn Beauchamp
Philip F Stahel
Wade R Smith
P2860
P2888
P304
P356
10.2119/2008-00050.BEAUCHAMP
P407
P577
2008-08-18T00:00:00Z
P5875
P6179
1068965085